Willeke F Westendorp
Overview
Explore the profile of Willeke F Westendorp including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
887
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Smith C, Heal C, Vail A, Jeans A, Westendorp W, Nederkoorn P, et al.
Front Neurol
. 2019 Jun;
10:504.
PMID: 31156537
Antibiotics used to treat post-stroke infections have differing antimicrobial and anti-inflammatory effects. Our aim was to investigate whether antibiotic class was associated with outcome after post-stroke infection. We analyzed pooled...
12.
Vermeij J, Westendorp W, van de Beek D, Nederkoorn P
Int J Stroke
. 2018 Sep;
13(9):913-920.
PMID: 30175940
This review provides an update of evidence on post-stroke infections and the use of preventive antibiotics in stroke. Infection is a common complication after stroke, affecting between 15% and 30%...
13.
de Ridder I, Dijkland S, Scheele M, den Hertog H, Dirks M, Westendorp W, et al.
Eur Stroke J
. 2018 Jun;
3(2):165-173.
PMID: 29900414
Introduction: We aimed to develop and validate a prognostic score for disability at discharge and functional outcome at three months in patients with acute ischemic stroke based on clinical information...
14.
Westendorp W, Vermeij J, Hilkens N, Brouwer M, Algra A, van der Worp H, et al.
Eur Stroke J
. 2018 Jun;
3(2):136-144.
PMID: 29900413
Introduction: Patients with acute stroke are at high risk for infection. These infections are associated with unfavourable outcome after stroke. A prediction rule can identify the patients at the highest...
15.
Groot A, Vermeij J, Westendorp W, Nederkoorn P, van de Beek D, Coutinho J
Stroke
. 2018 May;
49(7):1762-1765.
PMID: 29844030
Background And Purpose: There is no consensus on whether anticoagulation should be continued or temporarily stopped in patients suffering acute ischemic stroke while using anticoagulation. We assessed treatment variations and...
16.
Westendorp W, Zock E, Vermeij J, Kerkhoff H, Nederkoorn P, Dijkgraaf M, et al.
Neurology
. 2018 Apr;
90(18):e1553-e1560.
PMID: 29626176
Objective: To evaluate the cost-effectiveness of preventive ceftriaxone vs standard stroke unit care without preventive antimicrobial therapy in acute stroke patients. Methods: In this multicenter, randomized, open-label trial with masked...
17.
Vermeij J, Westendorp W, Dippel D, van de Beek D, Nederkoorn P
Cochrane Database Syst Rev
. 2018 Jan;
1:CD008530.
PMID: 29355906
Background: Stroke is the main cause of disability in high-income countries and ranks second as a cause of death worldwide. Infections occur frequently after stroke and may adversely affect outcome....
18.
Zonneveld T, Nederkoorn P, Westendorp W, Brouwer M, van de Beek D, Kruyt N
Neurology
. 2017 Mar;
88(15):1415-1421.
PMID: 28283600
Objective: To investigate whether admission hyperglycemia predicts poststroke infections and, if so, whether poststroke infections modify the effect of admission hyperglycemia on functional outcome in ischemic stroke. Methods: We used...
19.
Westendorp W, Vermeij J, Brouwer M, Roos Y, Nederkoorn P, van de Beek D
Cerebrovasc Dis
. 2016 Oct;
42(5-6):506-511.
PMID: 27701170
Background: Stroke-associated infections occur frequently and are associated with unfavorable outcome. Previous cohort studies suggest a protective effect of beta-blockers (BBs) against infections. A sympathetic drive may increase immune suppression...
20.
Vermeij J, Westendorp W, Roos Y, Brouwer M, van de Beek D, Nederkoorn P
Cerebrovasc Dis
. 2016 Jun;
42(5-6):361-369.
PMID: 27336314
Background: The Preventive Antibiotics in Stroke Study (PASS), a randomized open-label masked endpoint trial, showed that preventive ceftriaxone did not improve functional outcome at 3 months in patients with acute...